glun2b  (R&D Systems)

Journal: Pharmacology Research & Perspectives

Article Title: Combined Inhibition of TRPM 4/ NMDA Receptor Complex and Extrasynaptic NMDA Receptors Is Candidate Therapeutic Target for Suppression of Epileptic Seizures and Improvement of Cognitive Impairments

doi: 10.1002/prp2.70256

Figure Lengend Snippet: Expression of GluN2A (A) and GluN2B (B) and basal extracellular levels of L‐glutamate (C) and D‐serine (D) in 4‐weeks and 8‐weeks of age S286L‐TG and wild‐type littermate. Ordinates indicate mean ± SD ( n = 6) of (A) expression levels of GluN2A relative to GAPDH in the plasma membrane fraction (B) expression levels of GluN2B relative to GAPDH in the plasma membrane fraction, (C) basal extracellular L‐glutamate level (μM) and (D) basal extracellular D‐serine level (μM) in the frontal cortex of wild‐type (gray column) and S286L‐TG (blue column). The lower‐side panels in A and B indicate pseudo‐gel images of capillary immunoblotting. Circles indicate the values of each individual rat. * p < 0.05, relative to 4‐weeks of age (4 W) and # p < 0.05 relative to wild‐type using two‐way ANOVA with Scheffe's post hoc test. F ‐values were in (A) expression of GluN2A ( F age [1, 20] = 46.7 [ p < 0.05], F genotype [1, 20] = 5.34 [ p < 0.05], F age*genotype [1, 20] = 1.1 [ p > 0.05]), (B) expression of GluN2B ( F age [1, 20] = 22.4 [ p < 0.05], F genotype [1, 20] = 8.3 [ p < 0.05], F age*genotype [1, 20] = 2.0 [ p > 0.05]), (C) L‐glutamate level ( F age [1, 20] = 3.2 [ p > 0.05], F genotype [1, 20] = 21.2 [ p < 0.05], F age*genotype [1, 20] = 1.9 [ p > 0.05]) and (D) D‐serine level ( F age [1, 20] = 8.4 [ p < 0.05], F genotype [1, 20] = 21.6 [ p < 0.05], F age*genotype [1, 20] = 2.8 [ p > 0.05]).

Article Snippet: Primary antibodies against GAPDH (NB300‐327, RRID:AB_10001915, 1:300; Novus Biologicals, Littleton, CO, USA), GluN2A (PPS012, RRID:AB_2112297, 1:100, R&D Systems, Minneapolis, MN, USA), GluN2B (PPS013, RRID:AB_562667, 1:100, R&D Systems), cAMP response element binding protein (CREB) (#4820, 1:50, Cell Signaling Technology, Danvers, MA, USA), and pCREB (#9198, 1:50, Cell Signaling) were used.

Techniques: Expressing, Clinical Proteomics, Membrane, Western Blot

Journal: Pharmacology Research & Perspectives

Article Title: Combined Inhibition of TRPM 4/ NMDA Receptor Complex and Extrasynaptic NMDA Receptors Is Candidate Therapeutic Target for Suppression of Epileptic Seizures and Improvement of Cognitive Impairments

doi: 10.1002/prp2.70256

Figure Lengend Snippet: Effects of chronic administration of probenecid, MK‐801, memantine, and FP802 on expression of GluN2A and GluN2B in S286L‐TG and wild‐type littermates. All rats were chronically administered by vehicle (control), probenecid (PBN: 100 mg/kg/day), MK‐801 (0.1 mg/kg/day), memantine (MEM: 10 mg/kg/day) and FP802 (40 mg/kg/day) for 2‐weeks (from 6‐weeks to 8‐weeks of age). Ordinates indicate mean ± SD ( n = 6) of expression levels of GluN2A (A1‐A4) and GluN2B (B1‐B4) relative to GAPDH in wild‐type (A1‐A2, B1‐B2) and S286L‐TG (A3‐A4, B3‐B4). The right‐side panels indicate pseudo‐gel images of capillary immunoblotting. Circles indicate the values of each individual rat. * p < 0.05, relative to control using one‐way ANOVA with Scheffe's post hoc test. F ‐values regarding effects of probenecid and MK‐801 on GluN2A expression in wild‐type (A1) ( F [2, 15] = 7.8 [ p < 0.05]), GluN2A in S286L (A3) ( F [2, 15] = 19.4 [ p < 0.05]), GluN2B in wild‐type (B1) ( F [2, 15] = 12.1 [ p < 0.05]) and GluN2B in S286L‐TG (B3) ( F [2, 15] = 18.2 [ p < 0.05]). F ‐values regarding effects of memantine and FP802 on GluN2A in wild‐type (A2) ( F [2, 15] = 0.4 [ p > 0.05]), GluN2A in S286L‐TG (A4) ( F [2, 15] = 7.1 [ p < 0.05]), GluN2B in wild‐type (B2) ( F [2, 15] = 0.2 [ p > 0.05]) and GluN2B in S286L‐TG (B4) ( F [2, 15] = 4.8 [ p < 0.05]).

Article Snippet: Primary antibodies against GAPDH (NB300‐327, RRID:AB_10001915, 1:300; Novus Biologicals, Littleton, CO, USA), GluN2A (PPS012, RRID:AB_2112297, 1:100, R&D Systems, Minneapolis, MN, USA), GluN2B (PPS013, RRID:AB_562667, 1:100, R&D Systems), cAMP response element binding protein (CREB) (#4820, 1:50, Cell Signaling Technology, Danvers, MA, USA), and pCREB (#9198, 1:50, Cell Signaling) were used.

Techniques: Expressing, Control, Western Blot

Journal: Pharmacology Research & Perspectives

Article Title: Combined Inhibition of TRPM 4/ NMDA Receptor Complex and Extrasynaptic NMDA Receptors Is Candidate Therapeutic Target for Suppression of Epileptic Seizures and Improvement of Cognitive Impairments

doi: 10.1002/prp2.70256

Figure Lengend Snippet: Effects of chronic combined administration of memantine with FP802 on ADSHE seizure frequency (A), sucrose preference (B), expression of GluN2A (C1) and GluN2B (C2), and basal extracellular levels of L‐glutamate (D) and D‐serine (E) in S286L‐TG and wild‐type littermate. All rats were chronically administered by vehicle (control) and combined of memantine (MEM: 10 mg/kg/day) with FP802 (40 mg/kg/day) for 2‐weeks (from 6‐weeks to 8‐weeks of age). Ordinates indicate mean ± SD ( n = 6) of (A) ADSHE seizure frequency (count h −1 ), (B) consumption of sucrose preference (%), (C1) expression levels of GluN2A relative to GAPDH, (C2) expression levels of GluN2B relative to GAPDH, (D) basal extracellular L‐glutamate level (μM) and (E) basal extracellular D‐serine level (μM). The right‐side panels in C1‐C2 indicate pseudo‐gel images of capillary immunoblotting. Circles indicate the values of each individual rat. * p < 0.05, relative to control and # p < 0.05 relative to wild‐type using student T ‐test or one‐way or two‐way ANOVA with Scheffe's post hoc test. F ‐values were in (B) sucrose preference: MEM ( F memantine+FP802 [1, 20] = 21.3 [ p < 0.05], F genotype [1, 20] = 5.1 [ p < 0.05], F rmemantine+FP802*genotype [1, 20] = 5.3 [ p < 0.05]), (D) L‐glutamate level: ( F memantine+FP802 [1, 20] = 5.3 [ p < 0.05], F genotype [1, 20] = 15.9 [ p < 0.05], F rmemantine+FP802*genotype [1, 20] = 4.8 [ p < 0.05]), (E) D‐serine level: ( F memantine+FP802 [1, 20] = 7.6 [ p < 0.05], F genotype [1, 20] = 22.4 [ p < 0.05], F rmemantine+FP802*genotype [1, 20] = 10.4 [ p < 0.05]).

Article Snippet: Primary antibodies against GAPDH (NB300‐327, RRID:AB_10001915, 1:300; Novus Biologicals, Littleton, CO, USA), GluN2A (PPS012, RRID:AB_2112297, 1:100, R&D Systems, Minneapolis, MN, USA), GluN2B (PPS013, RRID:AB_562667, 1:100, R&D Systems), cAMP response element binding protein (CREB) (#4820, 1:50, Cell Signaling Technology, Danvers, MA, USA), and pCREB (#9198, 1:50, Cell Signaling) were used.

Techniques: Expressing, Control, Western Blot

Journal: Experimental & Molecular Medicine

Article Title: HMGCS2-dependent β-OHB/H3K9bhb ameliorates synaptic plasticity and cognition in Alzheimer’s disease

doi: 10.1038/s12276-026-01664-9

Figure Lengend Snippet: a , b , The representative immunoblots ( a ) and quantitative analyses ( b ) of Glun1, Glun2A, Glun2B and Syn1 in the hippocampus of the WT, 3xTg-AD and 3xTg-AD+β-OHB mice, n = 4 per group. c , RT–qPCR assays mRNA expression of the Glun1, Glun2A, Glun2B and Syn1 in the hippocampus of the WT, 3xTg-AD and 3xTg-AD+β-OHB mice, n = 5 per group. d , ChIP–qPCR analysis of the enrichment of H3K9bhb at Glun1, Glun2A, Glun2B, Glun2C and Syn1 promoters in the hippocampus of the WT, 3xTg-AD and 3xTg-AD+β-OHB mice, n = 5 per group. e , f , Supplementing with β-OHB could increase the density of 3xTg-AD dendritic spines detected by Golgi-cox staining; the representative images ( e ) and quantitative analysis ( f ) of spine, n = 5 per group, three fields per mice. Scale bar, 5 μm. g – j , The Sholl analysis showed the synaptic complexity of neurons after supplementing with β-OHB in 3xTg-AD mice; the representative images ( g and i ) and the quantitative analysis ( h and j ), n = 5 per group, two fields per mice. Scale bar, 50 μm. Data are shown as mean ± s.e.m. One-way ANOVA followed by Bonferroni’s post hoc test for b – d and f . Two-way ANOVA followed by Bonferroni’s post hoc test for i and k . * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001; ns, not significant.

Article Snippet: GluN2B , NMDAR2B , Poly- , 1:1000 , Proteintech , 21920-1-AP.

Techniques: Western Blot, Quantitative RT-PCR, Expressing, ChIP-qPCR, Staining

Journal: Experimental & Molecular Medicine

Article Title: HMGCS2-dependent β-OHB/H3K9bhb ameliorates synaptic plasticity and cognition in Alzheimer’s disease

doi: 10.1038/s12276-026-01664-9

Figure Lengend Snippet: a – c , The HMGCS2 upregulation promotes the protein ( a and b ) and mRNA ( c ) expression of H3K9bhb, Glun1, Glun2A, Glun2B, Syn1 and PSD95, n = 4 or 5 per group. d , e , ChIP–qPCR analyses of the enrichment of H3K9bhb at Glun1, Glun2A, Glun2B and Syn1 promoters in the primary neurons of the WT, 3xTg-AD and 3xTg-AD + HMGCS2 mice n = 5 per group ( d ) and representative gel images from ChIP–qPCR assays ( e ). f – j , The HMGCS2 upregulation promotes the expression of Syn1 (scale bar, 25 μm) ( f ); n = 10 cells per group in MAP2 immunofluorescence ( g ) and quantitative analysis ( h ), n = 10 cells per group and SYP ( i and j ), n = 10 cells per group, scale bar, 15 μm. Data are shown as mean ± s.e.m. One-way ANOVA followed by Bonferroni’s post hoc test for b – d and j . Two-way ANOVA followed by Bonferroni’s post hoc test for h . * P < 0.05, ** P < 0.01 , *** P < 0.001, **** P < 0.0001; ns, not significant.

Article Snippet: GluN2B , NMDAR2B , Poly- , 1:1000 , Proteintech , 21920-1-AP.

Techniques: Expressing, ChIP-qPCR, Immunofluorescence

Journal: Experimental & Molecular Medicine

Article Title: HMGCS2-dependent β-OHB/H3K9bhb ameliorates synaptic plasticity and cognition in Alzheimer’s disease

doi: 10.1038/s12276-026-01664-9

Figure Lengend Snippet: a , b , A western blot analysis ( a ) of hippocampal lysates shows that HMGCS2 upregulation increases the protein levels ( b ) of H3K9bhb, Glun1, Glun2A, Glun2B, Syn1 and PSD95, n = 3 per group. c , The ChIP–qPCR analysis of H3K9bhb enrichment at the promoters of Glun2A , Glun2B , Syn1 and PSD95 in the four groups, n = 5 per group. d , The mRNA levels of Glun1, Glun2A, Glun2B, Syn1 and PSD95 in the hippocampus, as determined by RT–qPCR, n = 5 per group. e , f , Golgi staining reveals increased dendritic spine density in 3xTg-AD mice following overexpression of HMGCS2; representative images ( e ) and quantification ( f ) are shown, n = 5 per group, three fields per mice. Scale bar, 5 μm. g – j , A behavioral assessment of spatial learning and memory using the MWM, NOR and contextual fear conditioning tests: area under the curve (AUC) of escape latency during MWM training of day 1–6 ( g ), escape latency on day 7 of the MWM test ( h ), NOR discrimination index ( i ), freezing time on day 7 in the contextual fear conditioning test ( j ), n = 8 per group. Data are shown as mean ± s.e.m. One-way ANOVA followed by Bonferroni’s post hoc test for b – d , f and g – j . * P < 0.05, ** P < 0.01 , *** P < 0.001, **** P < 0.0001; ns, not significant.

Article Snippet: GluN2B , NMDAR2B , Poly- , 1:1000 , Proteintech , 21920-1-AP.

Techniques: Western Blot, ChIP-qPCR, Quantitative RT-PCR, Staining, Over Expression

Journal: The Journal of Biological Chemistry

Article Title: A GluN2B disease-associated variant promotes the degradation of NMDA receptors via autophagy

doi: 10.1016/j.jbc.2026.111147

Figure Lengend Snippet: Molecular characterization of the disease-associated variant GluN2B_R519Q . A , structure of the rat tetrameric GluN1_GluN2B NMDA receptor in complex with glutamate, with the GluN1 subunit in gray , and the GluN2B subunit in blue (PDB: 9ARI ) . The amino-terminal domain (ATD), ligand-binding domain (LBD), and transmembrane domain (TMD) are shown in ribbon format with the R519 residue selected for study in yellow spheres. B , structural model displaying residues involved in the glutamate binding site of the WT GluN2B subunit are represented as sticks, with the glutamate ligand in pink ( upper ). In silico mutagenesis of the R519 residue to a glutamine eliminates the electrostatic interaction with glutamate ( lower ). C , effects of R519Q on total GluN2B protein expression levels 48 h post transient transfection of HEK293T with GluN1 and GluN2B constructs at a 1:1 ratio to express WT or GluN2B_R519Q variant NMDARs. β-actin serves as the soluble total protein loading control (n = 7). D , surface biotinylation assay to monitor the influence of the R519Q DAV on the surface expression of NMDARs 48 h post transient transfection. Na + /K + ATPase served as a membrane protein loading control (n = 8). E , HEK293T cells stably expressing WT or R519Q GluN2B NMDARs were subjected to cycloheximide (100 μg/ml) for the indicated times to determine the stability and rate of degradation. β-actin serves as the soluble total protein loading control (n = 5). Statistical significance was determined by a two-way repeated measures analysis of variance (ANOVA) followed by a post hoc Tukey test for comparison in multiple groups. F , immunofluorescence images of GluN2B ( green ) and calnexin ( red ), an ER marker to assess ER accumulation (scale bar = 10 μm). Pearson’s coefficients are reported (n > 30 cells) and statistical significance was determined using a Mann-Whitney test. All data are normalized to the appropriate loading control, and data are presented as mean ± SD. Statistical significance was determined using an unpaired two-tailed Student’s t test between two groups for ( C ) and ( D ). Significance level defined as ∗ p < 0.05, ∗∗∗∗ p < 0.0001.

Article Snippet: The pre-cleared lysates were incubated with 2 μg of mouse anti-GluN2B antibody (NeuroMab #75–097) for 1 h at 4 °C, and then 50 μl of Protein A/G-plus agarose beads were added and incubated overnight at 4 °C.

Techniques: Variant Assay, Ligand Binding Assay, Residue, Binding Assay, In Silico, Mutagenesis, Expressing, Transfection, Construct, Control, Surface Biotinylation Assay, Membrane, Stable Transfection, Comparison, Immunofluorescence, Marker, MANN-WHITNEY, Two Tailed Test

Journal: The Journal of Biological Chemistry

Article Title: A GluN2B disease-associated variant promotes the degradation of NMDA receptors via autophagy

doi: 10.1016/j.jbc.2026.111147

Figure Lengend Snippet: The GluN2B subunit undergoes degradation via autophagy . A , inhibition of the proteasome with MG132 (10 μM) and the lysosome with Bafilomycin-A1 (1 μM) for 6 h effect on the GluN2B subunit in HEK293T cells stably expressing recombinant WT or R519Q NMDARs. β-actin serves as the soluble total protein loading control (n = 5). B , effects of R519Q on total GluN2B protein expression levels 48 h post transient transfection with GluN1 and GluN2B constructs at a 1:1 ratio in ATG7 KO HEK293T to express WT or GluN2B_R519Q variant NMDARs. β-actin served as the soluble total protein loading control. (n = 6). C , surface biotinylation assay to monitor the influence of the R519Q DAV on the surface expression of NMDARs expressed in ATG7 KO HEK293T 48 h post transient transfection. Na + /K + ATPase served as a membrane protein loading control (n = 6). D , schematic of macroautophagy pathway, including induction, nucleation and formation of the isolation membrane, elongation, autophagosome formation, and fusion with the lysosome forming the autophagolysosome. Rapamycin is shown to inhibit mTOR, which results in autophagy activation, while 3-MA and Baf-A1 inhibit autophagy at different stages as shown. E , HEK293T cells stably expressing R519Q NMDARs were treated with autophagy activators (SMER28 10 μM, Rapamycin 100 nM) and inhibitors of autophagy (3-MA 50 mM and Baf-A1 20 nM) for 24 h. Changes to total GluN2B expression were monitored via immunoblot and p62 was used as a marker for autophagic flux. β-actin serves as the soluble total protein loading control (n = 3). F , siRNA knockdown of ATG7 effect on R519Q variant GluN2B expression and immunoblot was performed 48 h after knockdown. β-actin served as the soluble total protein loading control (n = 3). Non-targeting (NT) siRNA was used as a control for each condition, and two independent siRNA constructs were used to knockdown gene expression. G , siRNA knockdown of LC3b effects on R519Q variant GluN2B expression. Immunoblot performed 48 h after knockdown. β-actin served as the soluble total protein loading control (n = 3). Non-targeting siRNA was used as a control for each condition, and two independent siRNA constructs were used to knockdown gene expression. LC3-Pool contains two unique siRNAs for each of the LC3a, LC3b, and LC3c isoforms. All data are normalized to the appropriate loading control, and data are presented as mean ± SD. Statistical significance was determined using an unpaired two-tailed Student’s t test between two groups or an analysis of variance (ANOVA) followed by a post hoc Dunnett’s test for comparison in multiple groups. Significance level defined as ns, not significant, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Article Snippet: The pre-cleared lysates were incubated with 2 μg of mouse anti-GluN2B antibody (NeuroMab #75–097) for 1 h at 4 °C, and then 50 μl of Protein A/G-plus agarose beads were added and incubated overnight at 4 °C.

Techniques: Inhibition, Stable Transfection, Expressing, Recombinant, Control, Transfection, Construct, Variant Assay, Surface Biotinylation Assay, Membrane, Isolation, Activation Assay, Western Blot, Marker, Knockdown, Gene Expression, Two Tailed Test, Comparison

Journal: The Journal of Biological Chemistry

Article Title: A GluN2B disease-associated variant promotes the degradation of NMDA receptors via autophagy

doi: 10.1016/j.jbc.2026.111147

Figure Lengend Snippet: The ER-phagy receptor CCPG1 interacts with the R519Q GluN2B variant and promotes its degradation through ER-to-lysosome-associated degradation . A , essential membrane-bound ER-phagy receptors. CCPG1, SEC62, and FAM134b are generally located in the ER sheets, while RTN3L, TEX264, and ATL3 are in the ER tubules. All ER-phagy receptors contain at least one LIR, represented as red circles, but induce degradation of distinct ER subdomains and client proteins. B , co-immunoprecipitation of HEK293T cells exogenously expressing R519Q GluN2B variants was done to measure interaction with ER-phagy receptors present in ER sheets CCPG1, FAM134b, and SEC62. Cells were treated with Baf-A1 (20 nM for 24 h), 24 h post transient transfection to enrich autophagy proteins for interaction. Quantification of the ratio of the protein of interest to GluN2B post co-IP is shown in the right panel (n = 3). C , siRNA knockdown of CCPG1 effects on GluN2B expression in HEK293T cells stably expressing R519Q NMDARs. Immunoblots performed 48 h after knockdown. Non-targeting siRNA was used as a control for each condition, and four independent siRNA constructs were used to knockdown gene expression. β-actin served as the soluble total protein loading control (n = 3). D , Dose–response overexpression of CCPG1 cDNA in HEK293T cells stably expressing R519Q GluN2B variants NMDARs. Cells were harvested 24 h after transient transfection. β-actin served as the soluble total protein loading control (n = 3). All data are normalized to the appropriate loading control, and data are presented as mean ± SD. Statistical significance was determined using an unpaired two-tailed Student’s t test between two groups or an analysis of variance (ANOVA) followed by a post hoc Dunnett’s test for comparison in multiple groups. Significance level defined as ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Article Snippet: The pre-cleared lysates were incubated with 2 μg of mouse anti-GluN2B antibody (NeuroMab #75–097) for 1 h at 4 °C, and then 50 μl of Protein A/G-plus agarose beads were added and incubated overnight at 4 °C.

Techniques: Variant Assay, Membrane, Immunoprecipitation, Expressing, Transfection, Co-Immunoprecipitation Assay, Knockdown, Stable Transfection, Western Blot, Control, Construct, Gene Expression, Over Expression, Two Tailed Test, Comparison

Journal: The Journal of Biological Chemistry

Article Title: A GluN2B disease-associated variant promotes the degradation of NMDA receptors via autophagy

doi: 10.1016/j.jbc.2026.111147

Figure Lengend Snippet: The GluN2B LC3-interacting region (LIR) motif is highly conserved . A , canonical LC3-interacting motif consensus sequence pointing to the LIR motif identified in the GluN2B subunit and subsequent alanine substitution. Aromatic residue is shown in red, hydrophobic residue in blue. B , sequence alignment of Homo sapiens GluN2A and GluN2B CTD amino acid sequence in the region of interest. The LIR motif is in red in the GluN2B subunit. The serine residue that is phosphorylated by CAMKII is shown in green for each subunit. Asterisks mark conserved residues, colons mark conserved residues with similar properties, and a period denotes residues that are semi-conservative. C , amino acid sequence alignment of mammalian species demonstrating species conservation of the GluN2B CTD region of interest surrounding the LIR motif. D , effects of LIR motif disruption on WT, WT_F1307A and R519Q, R519Q_F1307A total GluN2B protein expression levels 48 h post transient transfection of HEK293T cells transfected with a 1:1 ratio of GluN1 and GluN2B constructs to express WT or GluN2B_R519Q variant NMDARs. β-actin served as the soluble total protein loading control (n = 4). E , surface biotinylation assay to monitor the influence of the LIR domain disruption on the WT and R519Q DAV surface expression of NMDARs 48 h post transient transfection Na + /K + ATPase served as a membrane protein loading control (n = 3). F , effects of LIR motif disruption on total expression of GluN2B subunits expressed in ATG7 KO cells. 48 h post transient transfection of GluN1 and GluN2B constructs with a 1:1 ratio of GluN1 and GluN2B constructs to express WT, WT_F1307A, R519Q, R519Q_F1307A variant NMDARs. β-actin served as the soluble total protein loading control (n = 4). G , surface biotinylation assay to monitor the influence of the LIR motif disruption on WT and the R519Q variant GluN2B subunits on the surface expression of NMDARs in ATG7 KO cells 48 h post transient transfection. Na + /K + ATPase served as a membrane protein loading control (n = 4). All data are normalized to the appropriate loading control, and data are presented as mean ± SD. Statistical significance was determined using an unpaired two-tailed Student’s t test between two groups or an analysis of variance (ANOVA) followed by a post hoc Tukey test for comparison in multiple groups. Significance level defined as ns, not significant, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Article Snippet: The pre-cleared lysates were incubated with 2 μg of mouse anti-GluN2B antibody (NeuroMab #75–097) for 1 h at 4 °C, and then 50 μl of Protein A/G-plus agarose beads were added and incubated overnight at 4 °C.

Techniques: Sequencing, Residue, Disruption, Expressing, Transfection, Construct, Variant Assay, Control, Surface Biotinylation Assay, Membrane, Two Tailed Test, Comparison

Journal: The Journal of Biological Chemistry

Article Title: A GluN2B disease-associated variant promotes the degradation of NMDA receptors via autophagy

doi: 10.1016/j.jbc.2026.111147

Figure Lengend Snippet: Effects of LIR motif disruption on GluN2B autophagic degradation . A , inhibition of the proteasome with MG132 (10 μM) and the lysosome with Baf-A1 (1 μM) for 6 h effect on the WT ( left ) and WT_F1307A ( right ) GluN2B subunit in HEK293T cells 48 h after transient transfection. β-actin served as the soluble total protein loading control (n = 5). B , inhibition of the proteasome with MG132 (10 μM) and the lysosome with Baf-A1 (1 μM) for 6 h effect on the R519Q ( left ) and the R519Q_F1307A ( right ) GluN2B subunit in HEK293T cells 48 h after transient transfection. β-actin served as the soluble total protein loading control (n = 5). C , ratio of the normalized accumulation of R519Q/WT GluN2B ( left ) and the ratio of the normalized accumulation of WT_F1307A/WT GluN2B ( right ) upon treatment with Baf-A1 and MG132. D , ratio of the normalized accumulation of R519Q_F1307A/WT_F1307A GluN2B ( left ) and the ratio of the normalized accumulation of R519Q_F1307A/R519Q GluN2B ( right ) upon treatment with Baf-A1 and MG132. E , co-immunoprecipitation of HEK293T cells exogenously expressing WT, R519Q, or R519Q_F1307A NMDARs with GluN2B variants was done to measure interaction with key autophagy proteins. Cells were treated with Baf-A1 (20 nM for 24 h), 24 h post transient transfection to enrich autophagy proteins for interaction. Quantification of the ratio of the protein of interest to GluN2B post co-IP is shown in the right panel (n = 3). All data are normalized to the appropriate loading control, and data are presented as mean ± SD. Statistical significance was determined using an unpaired two-tailed Student’s t test between two groups or an analysis of variance (ANOVA) followed by a post hoc Tukey test for comparison in multiple groups. Significance level defined as ns, not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Article Snippet: The pre-cleared lysates were incubated with 2 μg of mouse anti-GluN2B antibody (NeuroMab #75–097) for 1 h at 4 °C, and then 50 μl of Protein A/G-plus agarose beads were added and incubated overnight at 4 °C.

Techniques: Disruption, Inhibition, Transfection, Control, Immunoprecipitation, Expressing, Co-Immunoprecipitation Assay, Two Tailed Test, Comparison

Journal: The Journal of Biological Chemistry

Article Title: A GluN2B disease-associated variant promotes the degradation of NMDA receptors via autophagy

doi: 10.1016/j.jbc.2026.111147

Figure Lengend Snippet: Proposed mechanism of autophagic clearance of the GluN2B R519Q variant . The GluN2B R519Q variant fails quality control measures in the ER, resulting in its retention within the ER lumen. CCPG1, shown in red , present in the ER sheets, can recognize the misfolded and accumulating R519Q variant, blue , and targets it for autophagic degradation via recruitment of autophagy machinery via interactions with the LIR, shown as yellow circles , and FIR domains, shown in neon green , of CCPG1. It is also possible that the LIR domain present on the cytoplasmic CTD of the GluN2B subunit is able to interact with autophagy machinery directly.

Article Snippet: The pre-cleared lysates were incubated with 2 μg of mouse anti-GluN2B antibody (NeuroMab #75–097) for 1 h at 4 °C, and then 50 μl of Protein A/G-plus agarose beads were added and incubated overnight at 4 °C.

Techniques: Variant Assay, Control